This is a paid press release. Contact the press release distributor directly with any inquiries.
LataMed AI Begins Evaluating Global Healthcare Expansion Opportunities Through Planned Attendance at World Health Expo 2027
NewMediaWire
Mon, July 13, 2026 at 3:00 PM GMT+5:30
5 min read
- LMED
+35.10%
CARACAS, VENEZUELA – July 13, 2026 (NEWMEDIAWIRE) – LataMed AI Corp. (OTC: LMED) (the “Company”), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, today announced that management has begun planning for the Company’s anticipated attendance at the World Health Expo 2027 in Dubai, United Arab Emirates, as part of its broader strategy to evaluate international healthcare expansion opportunities.
Management believes attendance at World Health Expo 2027 will provide an important opportunity to engage with healthcare leaders, technology innovators, healthcare providers, government representatives, and potential strategic partners from around the world while evaluating opportunities beyond the Company’s current Latin American initiatives
The Company believes its planned participation is intended to support ongoing assessments of international commercialization opportunities for its developing digital healthcare ecosystem, including telehealth infrastructure, healthcare coordination technologies, pharmacy integration initiatives, insurance accessibility solutions, payment accessibility technologies, and artificial intelligence-driven healthcare platforms
Management further believes the World Health Expo may provide an opportunity to evaluate potential strategic relationships, licensing opportunities, and regional collaborations relating to the Company’s digital healthcare technologies while gaining additional insight into emerging trends in healthcare innovation, precision medicine, artificial intelligence, and digital health infrastructure
The Company noted that the planned participation builds upon its recent international engagement initiatives, including attendance at HLTH Europe, while complementing its continued expansion throughout Latin America, including recently announced strategic initiatives in Venezuela and the Company’s ongoing evaluation of expansion opportunities in Colombia
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “As we continue executing our long-term vision of building an integrated digital healthcare ecosystem, we believe it is important to evaluate opportunities beyond our existing markets. World Health Expo 2027 is expected to provide an outstanding opportunity to engage with healthcare leaders from around the world, better understand evolving global healthcare trends, and explore potential strategic relationships that may support the continued development and international expansion of the LataMed AI platform.”
